Subtype
Pancreatic Neoplasm
CI-CAN-00001356Explore in graph →
Non-malignant988 active trials8 approved drugs63 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001356Explore in graph →
Clinical trials
4,217 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02400398 | Evaluating Weight Stability of Pancreatic Cancer Cachexia Patients(PanCax) | completed | — | 30 | Andrew Hendifar, MDOTHER | 1 | Aug 11, 2020 | clinicaltrials |
| NCT01560949 | Preoperative Folfirinox, Radiation Therapy for Resectable Adenocarcinoma of the Pancreas | completed | Phase 2 | 34 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 10, 2020 | clinicaltrials |
| NCT02983500 | Patient Reported Outcomes Registry in Patient With Cancer Cachexia(PROXie) | completed | — | 253 | iOMEDICO AGINDUSTRY | 1 | Aug 7, 2020 | clinicaltrials |
| NCT00745381 | A Collection of Clinical and Epidemiologic Data Combined With Tissue and Blood From Patients With a Diagnosis of Neuroendocrine Tumors | completed | — | 238 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Aug 4, 2020 | clinicaltrials |
| NCT01485744 | LDE225 With Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan for Untreated Advanced Pancreatic Cancer | completed | Phase 1 | 39 | Massachusetts General HospitalOTHER | 1 | Aug 4, 2020 | clinicaltrials |
| NCT04380766 | Covid-19 Pandemic and Pancreatic Surgery in Italy(PanCOVID) | completed | — | 730 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Aug 3, 2020 | clinicaltrials |
| NCT01222689 | Selumetinib and Erlotinib Hydrochloride in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer | completed | Phase 2 | 46 | National Cancer Institute (NCI)NIH | 1 | Jul 31, 2020 | clinicaltrials |
| NCT02292745 | Efficacy and Feasibility of Combining FOLFIRINOX and Stereotactic Radiotherapy for Patients With Irresectable Locally Advanced Pancreatic Cancer.(LAPC-1) | completed | N/A | 53 | Foundation for Liver ResearchOTHER | 1 | Jul 29, 2020 | clinicaltrials |
| NCT02092948 | Phase I Study to evaluate124I-A11 PSCA Minibody in Patients With Metastatic Prostate, Bladder and Pancreatic Cancer | completed | Phase 1 | 8 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Jul 27, 2020 | clinicaltrials |
| NCT02402062 | A Study to Assess the Safety and the Efficacy of the Combination of TH-302 and Sunitinib in Neuroendocrine Pancreatic Tumours | completed | Phase 2 | 17 | Grupo Espanol de Tumores NeuroendocrinosOTHER | 1 | Jul 27, 2020 | clinicaltrials |
| NCT02803814 | Pancreatoduodenectomy in Pancreatic and Periampullary Tumors(DUOPAN-EPAM) | completed | N/A | 154 | Fundación para la Investigación del Hospital Clínico de ValenciaOTHER | 1 | Jul 22, 2020 | clinicaltrials |
| NCT01839487 | PEGPH20 Plus Nab-Paclitaxel Plus Gemcitabine Compared With Nab-Paclitaxel Plus Gemcitabine in Participants With Stage IV Untreated Pancreatic Cancer | completed | Phase 2 | 279 | Halozyme TherapeuticsINDUSTRY | 1 | Jul 20, 2020 | clinicaltrials |
| NCT01908478 | Veliparib in Combination With Gemcitabine and Intensity Modulated Radiation Therapy in Patients With Pancreatic Cancer(VelGemRad) | completed | Phase 1 | 34 | Cedars-Sinai Medical CenterOTHER | 1 | Jul 15, 2020 | clinicaltrials |
| NCT03411200 | Patient Activation Through Counseling, Exercise and Mobilization(PACE-Mobil) | completed | N/A | 99 | Herlev and Gentofte HospitalOTHER | 1 | Jul 14, 2020 | clinicaltrials |
| NCT00576680 | RAD001 and Temozolomide in Patients With Advanced Pancreatic Neuroendocrine Tumors | completed | Phase 1 / Phase 2 | 43 | Dana-Farber Cancer InstituteOTHER | 1 | Jul 9, 2020 | clinicaltrials |
| NCT03415126 | A Study of ASN007 in Patients With Advanced Solid Tumors | completed | Phase 1 | 49 | Asana BioSciencesINDUSTRY | 1 | Jul 9, 2020 | clinicaltrials |
| NCT03168139 | Olaptesed (NOX-A12) Alone and in Combination With Pembrolizumab in Colorectal and Pancreatic Cancer(Keynote-559) | completed | Phase 1 / Phase 2 | 20 | TME Pharma AGINDUSTRY | 1 | Jul 8, 2020 | clinicaltrials |
| NCT04385147 | Advanced Endoscopy During COVID-19 | completed | — | 670 | Al-Azhar UniversityOTHER | 5 | Jul 8, 2020 | clinicaltrials |
| NCT02841436 | A Clinical Research About Using Irreversible Electroporation to Treat Locally Advanced Pancreatic Cancer | completed | N/A | 7 | National Taiwan University HospitalOTHER | 0 | Jul 7, 2020 | clinicaltrials |
| NCT02153450 | Stereotactic Radiosurgery and Metformin in Patients With Borderline-Resectable or Locally-Advanced Pancreatic Cancer | completed | Early Phase 1 | 8 | Case Comprehensive Cancer CenterOTHER | 1 | Jun 26, 2020 | clinicaltrials |
| NCT00313560 | ChemoRT With Adjuvant Chemo in Pancreatic Cancer (TARCEVA) | completed | Phase 2 | 48 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Jun 4, 2020 | clinicaltrials |
| NCT01803282 | Study to Evaluate the Safety and Tolerability of Andecaliximab as Monotherapy and in Combination With Chemotherapy in Participants With Advanced Solid Tumors | completed | Phase 1 | 236 | Gilead SciencesINDUSTRY | 1 | Jun 2, 2020 | clinicaltrials |
| NCT03914950 | TOF-18F-FDG-PET/CT in Patients With Suspected Pancreatic Cancer(TOF-P) | completed | N/A | 174 | Medical University of GrazOTHER | 0 | May 29, 2020 | clinicaltrials |
| NCT00255827 | Vaccine Treatment for Surgically Resected Pancreatic Cancer | completed | Phase 1 / Phase 2 | 7 | NewLink Genetics CorporationINDUSTRY | 1 | May 28, 2020 | clinicaltrials |
| NCT00569387 | Vaccine Study for Surgically Resected Pancreatic Cancer | completed | Phase 2 | 73 | NewLink Genetics CorporationINDUSTRY | 1 | May 28, 2020 | clinicaltrials |
| NCT01072981 | Immunotherapy Study for Surgically Resected Pancreatic Cancer | completed | Phase 3 | 722 | NewLink Genetics CorporationINDUSTRY | 1 | May 28, 2020 | clinicaltrials |
| NCT03829748 | Intermittent Suction Technique in the Diagnosis of Pancreatic Solid Lesions | completed | N/A | 33 | Fundación de Investigación Biomédica - Hospital Universitario de La PrincesaOTHER | 1 | May 22, 2020 | clinicaltrials |
| NCT02777463 | The Prediction Using Diffusion MRI of the Response Evaluation in BRPC in NAT.(DIFFERENT) | completed | — | 28 | Wakayama Medical UniversityOTHER | 1 | May 20, 2020 | clinicaltrials |
| NCT04395898 | Pancreaticoduodenectomy: Outcomes of a Complex Surgical Procedure From a Developing Country | completed | — | 161 | Shaukat Khanum Memorial Cancer Hospital & Research CentreOTHER | 1 | May 20, 2020 | clinicaltrials |
| NCT01896869 | FOLFIRINOX Followed by Ipilimumab With Pancreatic Tumor Vaccine in Treatment of Metastatic Pancreatic Cancer | completed | Phase 2 | 83 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | May 19, 2020 | clinicaltrials |
| NCT02261714 | Antigen-specific Cancer Immunotherapy (TG01) and Gemcitabine as Adjuvant Therapy in Resected Pancreatic Cancer | completed | Phase 1 / Phase 2 | 32 | Targovax ASAINDUSTRY | 3 | May 14, 2020 | clinicaltrials |
| NCT01643499 | Genotype-guided Dosing of mFOLFIRINOX Chemotherapy in Patients With Previously Untreated Advanced Gastrointestinal Malignancies | completed | Phase 1 | 79 | University of ChicagoOTHER | 1 | May 8, 2020 | clinicaltrials |
| NCT02115022 | EUS vs. MDCT in Pancreatic Malignancy(EUSPACT) | completed | — | 45 | Clinical Hospital ColentinaOTHER | 1 | Apr 28, 2020 | clinicaltrials |
| NCT02628860 | Efficacy of Ferric Carboxymaltose (Ferinject®) in Anemic Patients Anticipating Pancreatoduodenectomy(FCM) | completed | Phase 2 | 40 | National Cancer Center, KoreaOTHER_GOV | 1 | Apr 28, 2020 | clinicaltrials |
| NCT03494023 | EUS Evaluation of CBD Diameter in Malignant Obstructive Jaundice(ECCO) | completed | — | 539 | Clinical Hospital ColentinaOTHER | 1 | Apr 28, 2020 | clinicaltrials |
| NCT00602602 | Bevacizumab, Combination Chemotherapy, and Radiation Therapy in Treating Patients Undergoing Surgery For Locally Advanced Pancreatic Cancer | completed | Phase 2 | 19 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Apr 27, 2020 | clinicaltrials |
| NCT04361682 | Preoperative Inflammatory Biomarkers and Postoperative Day 1 Drain Amylase Value Predict Pancreatic Fistula After Pancreaticoduodenectomy | completed | — | 227 | Campus Bio-Medico UniversityOTHER | 0 | Apr 24, 2020 | clinicaltrials |
| NCT02691052 | Observational Study on Quality of Life of Patients Receiving Nab-paclitaxel/Gemcitabine First Line Therapy, Including a Translational Program(QoliXane) | completed | — | 600 | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus NordwestOTHER | 1 | Apr 21, 2020 | clinicaltrials |
| NCT04348084 | Oncologic Impact of Pancreatic Fistula(POPF-DSS) | completed | — | 382 | University Hospital, MontpellierOTHER | 1 | Apr 16, 2020 | clinicaltrials |
| NCT00077519 | Tipifarnib and Radiation Therapy in Treating Patients With Unresectable Locally Advanced Pancreatic Cancer | completed | Phase 1 | 18 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Apr 15, 2020 | clinicaltrials |
| NCT02043288 | Combination Therapy With NC-6004 and Gemcitabine Versus Gemcitabine Alone in Pancreatic Cancer | completed | Phase 3 | 310 | Orient Europharma Co., Ltd.INDUSTRY | 7 | Apr 15, 2020 | clinicaltrials |
| NCT02698137 | Quality Assessment in Endoscopic Retrograde Cholangiopancreatography(ERCP)(QUASIE2) | completed | — | 1,843 | Clinical Hospital ColentinaOTHER | 3 | Apr 9, 2020 | clinicaltrials |
| NCT00454363 | Pazopanib Hydrochloride in Treating Patients With Advanced Neuroendocrine Cancer | completed | Phase 2 | 52 | National Cancer Institute (NCI)NIH | 1 | Apr 3, 2020 | clinicaltrials |
| NCT00026338 | Gemcitabine With/Out Erlotinib in Unresectable Locally Advanced/Metastatic Pancreatic Cancer | completed | Phase 3 | 569 | NCIC Clinical Trials GroupNETWORK | 19 | Apr 2, 2020 | clinicaltrials |
| NCT02671357 | Enhanced Recovery After Minimally Invasive Pancreaticoduodenectomy(ERAMIP) | completed | — | 210 | University Hospital, GasthuisbergOTHER | 1 | Mar 26, 2020 | clinicaltrials |
| NCT02841865 | Radiological Response of Pancreatic Neuroendocrine Tumors: Comparison Between the Choi and the RECIST Criteria(CRIPNET) | completed | — | 104 | Grupo Espanol de Tumores NeuroendocrinosOTHER | 1 | Mar 24, 2020 | clinicaltrials |
| NCT02101918 | Ziv-Aflibercept in Treating and Computed Tomography Perfusion Imaging in Predicting Response in Patients With Pancreatic Neuroendocrine Tumors That Are Metastatic or Cannot Be Removed by Surgery | completed | Phase 2 | 22 | National Cancer Institute (NCI)NIH | 1 | Mar 23, 2020 | clinicaltrials |
| NCT04317352 | Multivisceral Resection in Distal Pancreatectomy(ERPANDIS-MRV) | completed | — | 435 | Universidad de ExtremaduraOTHER | 1 | Mar 23, 2020 | clinicaltrials |
| NCT01677312 | Trial Comparing 19 and 25-gauge EUS-FNA Needles(EUS-FNA) | completed | N/A | 72 | AdventHealthOTHER | 1 | Mar 17, 2020 | clinicaltrials |
| NCT04133155 | Retrospective Analysis of 2nd-line Nab-Paclitaxel + Gemcitabine After 1st-line FOLFIRINOX in Pancreatic Cancer | completed | — | 103 | Asan Medical CenterOTHER | 1 | Mar 13, 2020 | clinicaltrials |
Data updated 24 days agoSource updated Aug 11, 2020source: clinicaltrials